| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | xylose binding | 2.53e-05 | 2 | 101 | 2 | GO:0033222 | |
| GeneOntologyMolecularFunction | semaphorin receptor activity | 2.67e-05 | 12 | 101 | 3 | GO:0017154 | |
| GeneOntologyMolecularFunction | mediator complex binding | 1.51e-04 | 4 | 101 | 2 | GO:0036033 | |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | 1.73e-04 | 231 | 101 | 7 | GO:0005085 | |
| GeneOntologyMolecularFunction | D-glucose transmembrane transporter activity | 2.66e-04 | 25 | 101 | 3 | GO:0055056 | |
| GeneOntologyMolecularFunction | hexose transmembrane transporter activity | 2.66e-04 | 25 | 101 | 3 | GO:0015149 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 3.34e-04 | 118 | 101 | 5 | GO:0003774 | |
| GeneOntologyMolecularFunction | monosaccharide transmembrane transporter activity | 3.36e-04 | 27 | 101 | 3 | GO:0015145 | |
| GeneOntologyMolecularFunction | galactose transmembrane transporter activity | 3.75e-04 | 6 | 101 | 2 | GO:0005354 | |
| GeneOntologyMolecularFunction | sugar transmembrane transporter activity | 4.17e-04 | 29 | 101 | 3 | GO:0051119 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 4.38e-04 | 70 | 101 | 4 | GO:0003777 | |
| GeneOntologyMolecularFunction | dehydroascorbic acid transmembrane transporter activity | 6.95e-04 | 8 | 101 | 2 | GO:0033300 | |
| GeneOntologyMolecularFunction | galactoside binding | 8.91e-04 | 9 | 101 | 2 | GO:0016936 | |
| GeneOntologyMolecularFunction | carbohydrate transmembrane transporter activity | 1.25e-03 | 42 | 101 | 3 | GO:0015144 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | EVL MYH7 KIF1A CENPE SYNE1 KTN1 LMTK2 S100A9 KIF15 ENAH CEP135 CTNNA3 MACF1 SSH2 | 1.25e-03 | 1099 | 101 | 14 | GO:0008092 |
| GeneOntologyMolecularFunction | profilin binding | 1.91e-03 | 13 | 101 | 2 | GO:0005522 | |
| GeneOntologyMolecularFunction | D-glucose binding | 2.22e-03 | 14 | 101 | 2 | GO:0005536 | |
| GeneOntologyBiologicalProcess | male gamete generation | SYNE1 SPANXA1 TSGA10 SLC2A14 PIWIL4 CIT TP63 TTC12 ATM SSH2 CFAP69 SLC26A6 ZNF541 PMFBP1 | 1.44e-05 | 762 | 98 | 14 | GO:0048232 |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | GPM6A EVL KIF1A SYNE1 CIT PTPN5 S100A9 AP2A1 PLXNC1 TNN CEP135 PLXNA4 MACF1 PLXNA2 | 4.55e-05 | 846 | 98 | 14 | GO:0120035 |
| GeneOntologyBiologicalProcess | spermatogenesis | SYNE1 SPANXA1 TSGA10 SLC2A14 PIWIL4 CIT TP63 TTC12 SSH2 CFAP69 SLC26A6 ZNF541 PMFBP1 | 5.02e-05 | 744 | 98 | 13 | GO:0007283 |
| GeneOntologyBiologicalProcess | neuron development | GPM6A EVL PDE6C KIF1A SYNE1 LMTK2 REST KCNIP2 CIT PTPN5 S100A9 AP2A1 PLXNC1 GLI3 TNN ENAH PLXNA4 MACF1 PLXNA2 | 5.11e-05 | 1463 | 98 | 19 | GO:0048666 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | EVL KIF1A SYNE1 LMTK2 REST CIT PLXNC1 GLI3 TNN ENAH PLXNA4 MACF1 PLXNA2 | 5.31e-05 | 748 | 98 | 13 | GO:0048667 |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | GPM6A EVL KIF1A SYNE1 CIT PTPN5 S100A9 AP2A1 PLXNC1 TNN CEP135 PLXNA4 MACF1 PLXNA2 | 5.64e-05 | 863 | 98 | 14 | GO:0031344 |
| GeneOntologyBiologicalProcess | gamete generation | CENPE SYNE1 SPANXA1 TSGA10 SLC2A14 PIWIL4 CIT TP63 TTC12 ATM SSH2 CFAP69 SLC26A6 ZNF541 PMFBP1 | 5.92e-05 | 982 | 98 | 15 | GO:0007276 |
| GeneOntologyBiologicalProcess | vagus nerve development | 6.68e-05 | 3 | 98 | 2 | GO:0021564 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | GPM6A EVL KIF1A SYNE1 LMTK2 CIT PLXNC1 GLI3 TNN ENAH PLXNA4 MACF1 PLXNA2 | 1.07e-04 | 802 | 98 | 13 | GO:0048812 |
| GeneOntologyBiologicalProcess | neuron projection development | GPM6A EVL KIF1A SYNE1 LMTK2 REST CIT PTPN5 S100A9 AP2A1 PLXNC1 GLI3 TNN ENAH PLXNA4 MACF1 PLXNA2 | 1.08e-04 | 1285 | 98 | 17 | GO:0031175 |
| GeneOntologyBiologicalProcess | positive regulation of cell projection organization | GPM6A PTPN5 S100A9 AP2A1 PLXNC1 TNN CEP135 PLXNA4 MACF1 PLXNA2 | 1.21e-04 | 494 | 98 | 10 | GO:0031346 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | GPM6A EVL KIF1A SYNE1 LMTK2 CIT PLXNC1 GLI3 TNN ENAH PLXNA4 MACF1 PLXNA2 | 1.32e-04 | 819 | 98 | 13 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | GPM6A EVL KIF1A SYNE1 LMTK2 CIT PLXNC1 GLI3 TNN ENAH PLXNA4 MACF1 PLXNA2 | 1.44e-04 | 826 | 98 | 13 | GO:0048858 |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | KIF1A SYNE1 CIT PTPN5 S100A9 AP2A1 PLXNC1 TNN PLXNA4 MACF1 PLXNA2 | 1.55e-04 | 612 | 98 | 11 | GO:0010975 |
| GeneOntologyBiologicalProcess | glossopharyngeal nerve development | 2.21e-04 | 5 | 98 | 2 | GO:0021563 | |
| GeneOntologyBiologicalProcess | developmental process involved in reproduction | SYNE1 SPANXA1 TSGA10 SLC2A14 PIWIL4 CIT TP63 TTC12 ATM SSH2 HECTD1 CFAP69 NIPBL SLC26A6 ZNF541 PMFBP1 | 2.24e-04 | 1235 | 98 | 16 | GO:0003006 |
| GeneOntologyCellularComponent | semaphorin receptor complex | 3.02e-05 | 13 | 101 | 3 | GO:0002116 | |
| Domain | DOCK_N | 1.52e-06 | 5 | 101 | 3 | PF16172 | |
| Domain | DOCK_N | 1.52e-06 | 5 | 101 | 3 | IPR032376 | |
| Domain | ARM-type_fold | DOCK1 DOCK2 USP34 DOCK5 THADA AP2A1 TTC12 ATM HECTD1 CFAP69 NIPBL | 2.22e-06 | 339 | 101 | 11 | IPR016024 |
| Domain | Plexin_cytopl | 1.26e-05 | 9 | 101 | 3 | PF08337 | |
| Domain | Plexin_cytoplasmic_RasGAP_dom | 1.26e-05 | 9 | 101 | 3 | IPR013548 | |
| Domain | Plexin | 1.26e-05 | 9 | 101 | 3 | IPR031148 | |
| Domain | SPAN-X_fam | 1.79e-05 | 10 | 101 | 3 | IPR010007 | |
| Domain | SPAN-X | 1.79e-05 | 10 | 101 | 3 | PF07458 | |
| Domain | DOCK_C | 2.45e-05 | 11 | 101 | 3 | IPR010703 | |
| Domain | DHR-1_domain | 2.45e-05 | 11 | 101 | 3 | IPR027007 | |
| Domain | DHR_2 | 2.45e-05 | 11 | 101 | 3 | PS51651 | |
| Domain | DHR_1 | 2.45e-05 | 11 | 101 | 3 | PS51650 | |
| Domain | DOCK-C2 | 2.45e-05 | 11 | 101 | 3 | PF14429 | |
| Domain | DHR-2 | 2.45e-05 | 11 | 101 | 3 | IPR027357 | |
| Domain | DHR-2 | 2.45e-05 | 11 | 101 | 3 | PF06920 | |
| Domain | DOCK | 2.45e-05 | 11 | 101 | 3 | IPR026791 | |
| Domain | Glc_transpt_3 | 2.90e-05 | 2 | 101 | 2 | IPR002945 | |
| Domain | Recoverin | 4.22e-05 | 13 | 101 | 3 | IPR028846 | |
| Domain | VASP_tetra | 8.66e-05 | 3 | 101 | 2 | IPR014885 | |
| Domain | VASP_tetra | 8.66e-05 | 3 | 101 | 2 | PF08776 | |
| Domain | IPT | 4.09e-04 | 27 | 101 | 3 | SM00429 | |
| Domain | CH | 4.23e-04 | 65 | 101 | 4 | SM00033 | |
| Domain | CH | 5.62e-04 | 70 | 101 | 4 | PF00307 | |
| Domain | - | 5.93e-04 | 71 | 101 | 4 | 1.10.418.10 | |
| Domain | TIG | 6.18e-04 | 31 | 101 | 3 | PF01833 | |
| Domain | Sema | 6.18e-04 | 31 | 101 | 3 | SM00630 | |
| Domain | Semap_dom | 6.18e-04 | 31 | 101 | 3 | IPR001627 | |
| Domain | Sema | 6.18e-04 | 31 | 101 | 3 | PF01403 | |
| Domain | SEMA | 6.18e-04 | 31 | 101 | 3 | PS51004 | |
| Domain | Prefoldin | 6.25e-04 | 72 | 101 | 4 | IPR009053 | |
| Domain | CH | 6.59e-04 | 73 | 101 | 4 | PS50021 | |
| Domain | PSI | 6.79e-04 | 32 | 101 | 3 | PF01437 | |
| Domain | IPT | 6.79e-04 | 32 | 101 | 3 | IPR002909 | |
| Domain | Plexin_repeat | 6.79e-04 | 32 | 101 | 3 | IPR002165 | |
| Domain | CH-domain | 7.29e-04 | 75 | 101 | 4 | IPR001715 | |
| Domain | EF-hand_8 | 8.13e-04 | 34 | 101 | 3 | PF13833 | |
| Domain | EF-hand_7 | 1.17e-03 | 85 | 101 | 4 | PF13499 | |
| Domain | Rho_GTPase_activation_prot | 1.33e-03 | 88 | 101 | 4 | IPR008936 | |
| Domain | EF-hand_1 | 1.41e-03 | 152 | 101 | 5 | PF00036 | |
| Domain | WH1 | 1.54e-03 | 11 | 101 | 2 | SM00461 | |
| Domain | WH1/EVH1_dom | 1.54e-03 | 11 | 101 | 2 | IPR000697 | |
| Domain | WH1 | 1.54e-03 | 11 | 101 | 2 | PF00568 | |
| Domain | Kinesin-like_fam | 1.62e-03 | 43 | 101 | 3 | IPR027640 | |
| Domain | EFh | 1.68e-03 | 158 | 101 | 5 | SM00054 | |
| Domain | KINESIN_MOTOR_1 | 1.73e-03 | 44 | 101 | 3 | PS00411 | |
| Domain | - | 1.73e-03 | 44 | 101 | 3 | 3.40.850.10 | |
| Domain | Kinesin_motor_dom | 1.73e-03 | 44 | 101 | 3 | IPR001752 | |
| Domain | Kinesin | 1.73e-03 | 44 | 101 | 3 | PF00225 | |
| Domain | KINESIN_MOTOR_2 | 1.73e-03 | 44 | 101 | 3 | PS50067 | |
| Domain | PSI | 1.73e-03 | 44 | 101 | 3 | IPR016201 | |
| Domain | KISc | 1.73e-03 | 44 | 101 | 3 | SM00129 | |
| Domain | PSI | 1.97e-03 | 46 | 101 | 3 | SM00423 | |
| Domain | WH1 | 2.17e-03 | 13 | 101 | 2 | PS50229 | |
| Domain | Sugar/inositol_transpt | 2.53e-03 | 14 | 101 | 2 | IPR003663 | |
| Domain | EF_Hand_1_Ca_BS | 2.62e-03 | 175 | 101 | 5 | IPR018247 | |
| Domain | ARM-like | 3.48e-03 | 270 | 101 | 6 | IPR011989 | |
| Domain | SUGAR_TRANSPORT_2 | 3.73e-03 | 17 | 101 | 2 | PS00217 | |
| Domain | EF_HAND_1 | 5.03e-03 | 204 | 101 | 5 | PS00018 | |
| Pathway | REACTOME_PHASE_1_INACTIVATION_OF_FAST_NA_CHANNELS | 3.87e-06 | 7 | 69 | 3 | M27457 | |
| Pathway | REACTOME_PHASE_1_INACTIVATION_OF_FAST_NA_CHANNELS | 3.87e-06 | 7 | 69 | 3 | MM15199 | |
| Pathway | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | 2.14e-05 | 116 | 69 | 6 | MM15715 | |
| Pathway | REACTOME_RHOG_GTPASE_CYCLE | 2.46e-05 | 71 | 69 | 5 | MM15604 | |
| Pathway | REACTOME_RHOG_GTPASE_CYCLE | 3.01e-05 | 74 | 69 | 5 | M41814 | |
| Pathway | REACTOME_OTHER_SEMAPHORIN_INTERACTIONS | 1.03e-04 | 19 | 69 | 3 | M10959 | |
| Pathway | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | 1.80e-04 | 170 | 69 | 6 | M941 | |
| Pathway | REACTOME_REGULATION_OF_NPAS4_GENE_TRANSCRIPTION | 2.34e-04 | 5 | 69 | 2 | M46435 | |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | 2.76e-04 | 184 | 69 | 6 | M41809 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 2.79e-04 | 261 | 69 | 7 | MM15676 | |
| Pathway | WP_NIPBL_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME | 6.49e-04 | 8 | 69 | 2 | M42528 | |
| Pathway | REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION | 8.31e-04 | 9 | 69 | 2 | MM15030 | |
| Pathway | REACTOME_VITAMIN_C_ASCORBATE_METABOLISM | 8.31e-04 | 9 | 69 | 2 | MM14769 | |
| Pubmed | 2.45e-08 | 3 | 102 | 3 | 18957440 | ||
| Pubmed | The cancer-testis antigens SPANX-A/C/D and CTAG2 promote breast cancer invasion. | 2.45e-08 | 3 | 102 | 3 | 26895102 | |
| Pubmed | Differential distribution of KChIPs mRNAs in adult mouse brain. | 9.78e-08 | 4 | 102 | 3 | 15363885 | |
| Pubmed | Structure, alternative splicing, and expression of the human and mouse KCNIP gene family. | 9.78e-08 | 4 | 102 | 3 | 16112838 | |
| Pubmed | 9.78e-08 | 4 | 102 | 3 | 18393943 | ||
| Pubmed | GPM6A DLGAP1 CENPE SYNE1 KTN1 MCC CIT TXLNA AP2A1 KIF15 SRGAP3 ENAH MACF1 SSH2 NIPBL | 1.43e-07 | 963 | 102 | 15 | 28671696 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | MYH7 KRT85 MCC SNRK RO60 LRRK1 KCNIP2 S100A9 CNNM4 TXLNA IGF2BP2 RPL7L1 SHCBP1 CEP135 KCNIP4 OXSR1 BCAR3 | 1.96e-07 | 1284 | 102 | 17 | 17353931 |
| Pubmed | Evidence showing an intermolecular interaction between KChIP proteins and Taiwan cobra cardiotoxins. | 2.44e-07 | 5 | 102 | 3 | 15184042 | |
| Pubmed | 2.44e-07 | 5 | 102 | 3 | 24365888 | ||
| Pubmed | 2.44e-07 | 5 | 102 | 3 | 16251457 | ||
| Pubmed | 2.44e-07 | 5 | 102 | 3 | 11133693 | ||
| Pubmed | 2.44e-07 | 5 | 102 | 3 | 14734458 | ||
| Pubmed | 2.44e-07 | 5 | 102 | 3 | 20073942 | ||
| Pubmed | 2.44e-07 | 5 | 102 | 3 | 12758128 | ||
| Pubmed | 4.87e-07 | 6 | 102 | 3 | 20943905 | ||
| Pubmed | 6.69e-07 | 335 | 102 | 9 | 15741177 | ||
| Pubmed | EVL MYH7 SYNE1 PARP8 KTN1 AP2A1 TNN PLXNA4 CES3 NAV2 MACF1 ATM CFAP69 DNAH8 NIPBL PLXNA2 ZNF541 | 9.82e-07 | 1442 | 102 | 17 | 35575683 | |
| Pubmed | 1.35e-06 | 28 | 102 | 4 | 18617019 | ||
| Pubmed | 1.36e-06 | 8 | 102 | 3 | 15661641 | ||
| Pubmed | Proteomic analyses of native brain K(V)4.2 channel complexes. | 1.36e-06 | 8 | 102 | 3 | 19713751 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | DOCK1 EVL KIF1A KCNIP3 KCNIP2 DOCK5 CNNM4 THADA INTS2 NACC2 GCC2 TTC12 ENAH MACF1 OXSR1 HECTD1 CFAP69 | 1.52e-06 | 1489 | 102 | 17 | 28611215 |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 1.87e-06 | 281 | 102 | 8 | 28706196 | |
| Pubmed | 2.90e-06 | 10 | 102 | 3 | 17012309 | ||
| Pubmed | 5.10e-06 | 322 | 102 | 8 | 26514267 | ||
| Pubmed | Transmembrane semaphorin signalling controls laminar stratification in the mammalian retina. | 5.29e-06 | 12 | 102 | 3 | 21270798 | |
| Pubmed | 6.86e-06 | 13 | 102 | 3 | 21930703 | ||
| Pubmed | 6.86e-06 | 13 | 102 | 3 | 10520995 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 23615220 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 28324109 | ||
| Pubmed | Expression of the brain-type glucose transporter is restricted to brain and neuronal cells in mice. | 8.52e-06 | 2 | 102 | 2 | 1516757 | |
| Pubmed | Glucose Transporter 3 Potentiates Degranulation and Is Required for Platelet Activation. | 8.52e-06 | 2 | 102 | 2 | 28663252 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 18769144 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 19506559 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 25892112 | ||
| Pubmed | Ubiquitin-specific protease 34 in macrophages limits CD8 T cell-mediated onset of vitiligo in mice. | 8.52e-06 | 2 | 102 | 2 | 37043976 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 33368883 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 16951992 | ||
| Pubmed | Neuronal functions, feeding behavior, and energy balance in Slc2a3+/- mice. | 8.52e-06 | 2 | 102 | 2 | 18780771 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 8654954 | ||
| Pubmed | Targeting Ras-Driven Cancer Cell Survival and Invasion through Selective Inhibition of DOCK1. | 8.52e-06 | 2 | 102 | 2 | 28467910 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 25339677 | ||
| Pubmed | ATDC mediates a TP63-regulated basal cancer invasive program. | 8.52e-06 | 2 | 102 | 2 | 30643195 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 18269347 | ||
| Pubmed | Expression of mouse-GLUT3 and human-GLUT3 glucose transporter proteins in brain. | 8.52e-06 | 2 | 102 | 2 | 1734877 | |
| Pubmed | CTp11, a novel member of the family of human cancer/testis antigens. | 8.52e-06 | 2 | 102 | 2 | 10626816 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 31884568 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 33482226 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 23193055 | ||
| Pubmed | ENA/VASP downregulation triggers cell death by impairing axonal maintenance in hippocampal neurons. | 8.52e-06 | 2 | 102 | 2 | 20230896 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 8198523 | ||
| Pubmed | Glucose Transporter 3 is Essential for the Survival of Breast Cancer Cells in the Brain. | 8.52e-06 | 2 | 102 | 2 | 31817208 | |
| Pubmed | Brain glucose transporter (Glut3) haploinsufficiency does not impair mouse brain glucose uptake. | 8.52e-06 | 2 | 102 | 2 | 21316350 | |
| Pubmed | Altered lactate metabolism in Huntington's disease is dependent on GLUT3 expression. | 8.52e-06 | 2 | 102 | 2 | 29582588 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 22951905 | ||
| Pubmed | Transcriptional repressor DREAM regulates T-lymphocyte proliferation and cytokine gene expression. | 8.52e-06 | 2 | 102 | 2 | 16177826 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 22700768 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 18445753 | ||
| Pubmed | 8.71e-06 | 14 | 102 | 3 | 12432077 | ||
| Pubmed | SOX6 PARP8 MCC KCNIP2 TMPRSS11B TXLNA AP2A1 INTS2 THG1L ZNF541 PMFBP1 | 1.31e-05 | 750 | 102 | 11 | 11230166 | |
| Pubmed | 1.33e-05 | 16 | 102 | 3 | 17356169 | ||
| Pubmed | 1.53e-05 | 493 | 102 | 9 | 15368895 | ||
| Pubmed | 1.62e-05 | 17 | 102 | 3 | 11683995 | ||
| Pubmed | Semaphorin signaling facilitates cleft formation in the developing salivary gland. | 1.62e-05 | 17 | 102 | 3 | 17626059 | |
| Pubmed | GPM6A EVL DLGAP1 SYNE1 KTN1 SLC2A14 SPECC1 CIT SLC2A3 PITPNM1 AP2A1 SRGAP3 PLXNA4 MACF1 SSH2 | 1.84e-05 | 1431 | 102 | 15 | 37142655 | |
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 27397516 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 17296555 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 25578782 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 29614685 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 19728314 | ||
| Pubmed | A Requirement for Mena, an Actin Regulator, in Local mRNA Translation in Developing Neurons. | 2.55e-05 | 3 | 102 | 2 | 28735747 | |
| Pubmed | Glucose transporter GLUT3: ontogeny, targeting, and role in the mouse blastocyst. | 2.55e-05 | 3 | 102 | 2 | 9108057 | |
| Pubmed | Cell autonomous defects in cortical development revealed by two-color chimera analysis. | 2.55e-05 | 3 | 102 | 2 | 19386231 | |
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 18625214 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 36672824 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 34866525 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 12829703 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 24243341 | ||
| Pubmed | Role of transmembrane semaphorin Sema6A in oligodendrocyte differentiation and myelination. | 2.55e-05 | 3 | 102 | 2 | 22777942 | |
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 1730609 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 39430242 | ||
| Pubmed | Expression of SpanX proteins in normal testes and in testicular germ cell tumours. | 2.55e-05 | 3 | 102 | 2 | 16390498 | |
| Pubmed | Glucose transporter isoform-3 mutations cause early pregnancy loss and fetal growth restriction. | 2.55e-05 | 3 | 102 | 2 | 17213475 | |
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 14709716 | ||
| Pubmed | Gestational changes of glucose transporter gene expression in the mouse placenta and decidua. | 2.55e-05 | 3 | 102 | 2 | 8905482 | |
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 31561359 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 33586490 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 32285443 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 19550108 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 38246582 | ||
| Pubmed | Placental glucose transporter expression is regulated by glucocorticoids. | 2.55e-05 | 3 | 102 | 2 | 10199793 | |
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 7926364 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 35077394 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 9070948 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 19327547 | ||
| Pubmed | Glucose Metabolism Is Required for Platelet Hyperactivation in a Murine Model of Type 1 Diabetes. | 2.55e-05 | 3 | 102 | 2 | 30765335 | |
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 24913231 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 28746873 | ||
| Pubmed | DOCK2 regulates MRGPRX2/B2-mediated mast cell degranulation and drug-induced anaphylaxis. | 2.55e-05 | 3 | 102 | 2 | 36804596 | |
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 3170580 | ||
| Pubmed | Agrin has a pathological role in the progression of oral cancer. | 2.62e-05 | 197 | 102 | 6 | 29872149 | |
| Interaction | PFN1 interactions | THOC1 DOCK1 EVL KTN1 THADA STX5 KIF15 GCC2 TP63 ENAH MACF1 HECTD1 ZNF541 | 1.57e-06 | 509 | 101 | 13 | int:PFN1 |
| Interaction | SEMA6D interactions | 4.89e-06 | 23 | 101 | 4 | int:SEMA6D | |
| Interaction | YWHAZ interactions | EVL DLGAP1 PDE6C PARP8 MCC SPECC1 WTAP TXLNA KIF15 SRGAP3 GCC2 SHCBP1 ENAH CTNNA3 NAV2 MACF1 ATM SSH2 CEP126 HECTD1 | 7.33e-06 | 1319 | 101 | 20 | int:YWHAZ |
| Interaction | KCND2 interactions | 8.16e-06 | 26 | 101 | 4 | int:KCND2 | |
| Interaction | AGAP2 interactions | 1.07e-05 | 210 | 101 | 8 | int:AGAP2 | |
| Interaction | KIF20A interactions | ZFAT KIF1A CENPE SYNE1 KTN1 LRRK1 SPECC1 CIT DOCK5 IGF2BP2 RPL7L1 AP2A1 CEP135 NAV2 MACF1 SSH2 KLB | 1.76e-05 | 1052 | 101 | 17 | int:KIF20A |
| Cytoband | Xq27.1 | 7.08e-06 | 17 | 102 | 3 | Xq27.1 | |
| GeneFamily | Plexins | 2.60e-06 | 9 | 58 | 3 | 683 | |
| GeneFamily | Potassium voltage-gated channel regulatory subunits|DASH family | 1.39e-05 | 15 | 58 | 3 | 858 | |
| GeneFamily | ENAH/VASPs | 3.03e-05 | 3 | 58 | 2 | 946 | |
| GeneFamily | EF-hand domain containing | 7.06e-05 | 219 | 58 | 6 | 863 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 4.31e-04 | 46 | 58 | 3 | 622 | |
| GeneFamily | Protein tyrosine phosphatases, non-receptor type | 1.50e-03 | 18 | 58 | 2 | 812 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | SOX6 GPM6A KIF1A CENPE ICE2 KTN1 TSGA10 CIT CNNM4 KIF15 PLXNC1 SRGAP3 GCC2 GLI3 ENAH CEP135 NAV2 HECTD1 CFAP69 NIPBL | 2.48e-08 | 989 | 99 | 20 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | SOX6 GPM6A KIF1A CENPE ICE2 TSGA10 KCNIP3 CIT KIF15 NACC2 SRGAP3 GCC2 GLI3 ENAH CEP135 CES3 MACF1 ATM CEP126 NIPBL | 7.73e-08 | 1060 | 99 | 20 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5 | 1.40e-06 | 232 | 99 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.94e-06 | 311 | 99 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 3.27e-06 | 192 | 99 | 8 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | SOX6 GPM6A KIF1A CENPE KTN1 TSGA10 CIT KIF15 SRGAP3 GLI3 CEP135 NIPBL | 3.53e-06 | 498 | 99 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | SOX6 GPM6A KIF1A CENPE ICE2 TSGA10 KCNIP3 CIT KIF15 NACC2 SRGAP3 GCC2 GLI3 ENAH CEP135 CES3 MACF1 ATM CEP126 NIPBL | 6.93e-06 | 1414 | 99 | 20 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | CENPE ICE2 KTN1 REST CIT WTAP PTPN2 USP38 GLI3 ENAH MACF1 HECTD1 NIPBL | 7.15e-06 | 629 | 99 | 13 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | THOC1 GPM6A CENPE ICE2 SYNE1 KTN1 CIT WTAP USP38 GCC2 GLI3 TP63 MCM3AP ENAH MACF1 NIPBL | 1.29e-05 | 989 | 99 | 16 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 2.58e-05 | 185 | 99 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | SOX6 EVL CENPE KTN1 RO60 CIT KIF15 PLXNC1 GLI3 ENAH CEP135 HECTD1 CFAP69 NIPBL | 3.07e-05 | 831 | 99 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 3.27e-05 | 192 | 99 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | 3.40e-05 | 432 | 99 | 10 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | THOC1 SOX6 GPM6A KIF1A CENPE ICE2 KTN1 TSGA10 CIT KIF15 GCC2 GLI3 ENAH CEP135 CES3 MACF1 ATM CEP126 NIPBL | 3.85e-05 | 1459 | 99 | 19 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_top-relative-expression-ranked_1000 | SOX6 EVL MCC ITGA8 THSD7B IGF2BP2 PLXNC1 SRGAP3 GCC2 GLI3 CTNNA3 PLXNA4 NAV2 PLXNA2 | 4.35e-05 | 858 | 99 | 14 | gudmap_dev gonad_e11.5_F_GonMes_Sma_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000 | SOX6 GPM6A KIF1A CENPE KTN1 TSGA10 CIT KIF15 PLXNC1 SRGAP3 GCC2 MACF1 ATM CEP126 NIPBL | 5.04e-05 | 986 | 99 | 15 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 6.58e-05 | 291 | 99 | 8 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | THOC1 SOX6 KIF1A CENPE ICE2 KTN1 TSGA10 CIT KIF15 GCC2 GLI3 ENAH CEP135 MACF1 ATM CEP126 NIPBL | 6.59e-05 | 1257 | 99 | 17 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | 6.76e-05 | 469 | 99 | 10 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 7.77e-05 | 298 | 99 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 7.77e-05 | 298 | 99 | 8 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K4 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | SOX6 GPM6A CENPE MCC ITGA8 REST IGF2BP2 KIF15 PLXNC1 SRGAP3 GLI3 SHCBP1 PLXNA4 | 7.97e-05 | 793 | 99 | 13 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#2_top-relative-expression-ranked_1000 | 9.59e-05 | 98 | 99 | 5 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k2_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500 | 1.02e-04 | 493 | 99 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000 | SOX6 CENPE MCC ITGA8 THSD7B IGF2BP2 PLXNC1 SRGAP3 GCC2 GLI3 SHCBP1 PLXNA4 PLXNA2 | 1.21e-04 | 827 | 99 | 13 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | 1.90e-04 | 532 | 99 | 10 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | SOX6 KIF1A CENPE KTN1 CIT KIF15 NACC2 PLXNC1 GLI3 CEP135 CFAP69 | 2.35e-04 | 654 | 99 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | SOX6 GPM6A CENPE MCC ITGA8 THSD7B IGF2BP2 PLXNC1 SRGAP3 GLI3 SHCBP1 PLXNA4 | 2.65e-04 | 777 | 99 | 12 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_1000 | ICE2 MCC ITGA8 RO60 THSD7B PTPN2 IGF2BP2 PLXNC1 SRGAP3 PLXNA4 NAV2 PLXNA2 | 2.84e-04 | 783 | 99 | 12 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | 3.02e-04 | 564 | 99 | 10 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.11e-04 | 126 | 99 | 5 | gudmap_dev gonad_e11.5_F_GonMes_Sma_k2_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#4 | 3.80e-04 | 203 | 99 | 6 | Facebase_RNAseq_e9.5_Mandibular Arch_1000_K4 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_1000 | CENPE MCC ITGA8 THSD7B IGF2BP2 KIF15 PLXNC1 SRGAP3 GLI3 SHCBP1 PLXNA4 PLXNA2 | 4.85e-04 | 831 | 99 | 12 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 4.88e-04 | 139 | 99 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500 | 4.89e-04 | 492 | 99 | 9 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_top-relative-expression-ranked_1000 | SOX6 MCC ITGA8 THSD7B IGF2BP2 PLXNC1 SRGAP3 GCC2 GLI3 CTNNA3 PLXNA4 NAV2 | 5.86e-04 | 849 | 99 | 12 | gudmap_dev gonad_e11.5_M_GonMes_Sma_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000 | KIF1A CENPE KTN1 KCNIP3 GCC2 GLI3 TP63 ENAH CEP135 MACF1 CEP126 CFAP69 NIPBL | 6.16e-04 | 979 | 99 | 13 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000 |
| CoexpressionAtlas | B cells, proB.CLP.FL, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R- CD, Fetal Liver, avg-2 | 6.16e-04 | 83 | 99 | 4 | GSM538348_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | SOX6 GPM6A KIF1A CENPE KTN1 SPECC1 CIT KIF15 PLXNC1 SRGAP3 GCC2 GLI3 CEP135 | 6.40e-04 | 983 | 99 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 |
| CoexpressionAtlas | kidney_P0_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_100 | 7.58e-04 | 9 | 99 | 2 | gudmap_kidney_P0_CapMes_Crym_k4_100 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.37e-07 | 197 | 101 | 7 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_low-phase|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.55e-07 | 144 | 101 | 6 | f6061dd965a2b2fe6ad864f8aecc06d2e74881ce | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Basal_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.68e-06 | 172 | 101 | 6 | b66dbfff5e4f53ca8ece91ff9c5dc66a71f07c63 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 4.08e-06 | 185 | 101 | 6 | e06a784a297f357f3f8e761c24fa70722048ab42 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.21e-06 | 186 | 101 | 6 | 9feef5936985e936b3d88f9d1bb012abb6468570 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.21e-06 | 186 | 101 | 6 | 89f5b06bc56674af304912d481ac697c7c870904 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.76e-06 | 190 | 101 | 6 | d153a0bdedcd6865e6ee19575234a78b5d859ff1 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.76e-06 | 190 | 101 | 6 | e83fa8b711aa79a1767818474f1c193b674b1c31 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.21e-06 | 193 | 101 | 6 | 516ea2c12bdc7a5dc676159d627e36f6abe13ef0 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.36e-06 | 194 | 101 | 6 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.36e-06 | 194 | 101 | 6 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.52e-06 | 195 | 101 | 6 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | LPS_only-Endothelial-Endothelial-FOXM1|LPS_only / Treatment groups by lineage, cell group, cell type | 5.86e-06 | 197 | 101 | 6 | 038fd92750257d43d5e980fd06d77742b543f11a | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.39e-06 | 200 | 101 | 6 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_PP_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-05 | 154 | 101 | 5 | 2d98bb7a784fc3215e0d4a1670d662e5df4716c3 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_PP_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-05 | 154 | 101 | 5 | 0dec222101530f1727184dbb7c03969d3884f111 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_B-ABC_aged-B_naive|lymph-node_spleen / Manually curated celltypes from each tissue | 3.03e-05 | 158 | 101 | 5 | 7098847804dd90fa1dd74536e4e90f989b630fe4 | |
| ToppCell | droplet-Kidney-nan-3m-Lymphocytic-CD45____NK_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.51e-05 | 163 | 101 | 5 | a763c1632d6465a1e753bdc8eadaf819d2b09e5e | |
| ToppCell | droplet-Kidney-nan-3m-Lymphocytic-NK_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.51e-05 | 163 | 101 | 5 | eaed783eecd07aafa5af844b63c9d816b4da99e4 | |
| ToppCell | 10x5'-Lung-Hematopoietic_progenitors-Cycling_pre-Myeloid-2|Lung / Manually curated celltypes from each tissue | 3.94e-05 | 167 | 101 | 5 | 82739226347d74897be000f429b73543a031af96 | |
| ToppCell | 10x5'-Lung-Hematopoietic_progenitors|Lung / Manually curated celltypes from each tissue | 3.94e-05 | 167 | 101 | 5 | dec18caf0475002d4ad3c7bc7fc3050cbc8e6bae | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.06e-05 | 168 | 101 | 5 | 52fd65024af8683db11d931f7563cbe8eb815d1c | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Basal_1|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.29e-05 | 170 | 101 | 5 | aabe993c9f337b1caaeb0e64626a3920579c41b7 | |
| ToppCell | Immune-dendritic_cell|World / Lineage, Cell type, age group and donor | 4.41e-05 | 171 | 101 | 5 | 6a9e2e2d3e1d8cc475bf9765129bc4a32da3b8ea | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 4.41e-05 | 171 | 101 | 5 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Plasmacytoid_Dendritic_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.41e-05 | 171 | 101 | 5 | af1c93eb75f45c042ea475d93db56e4da207e31f | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.54e-05 | 172 | 101 | 5 | d354424c1f861b6607dfd63b9724f4c237b30275 | |
| ToppCell | Adult-Epithelial-basal_cell-D231|Adult / Lineage, Cell type, age group and donor | 4.79e-05 | 174 | 101 | 5 | a4f98afe7d1cc2617f6f7bc8092c41df57474b30 | |
| ToppCell | 10x5'-lymph-node_spleen-Hematopoietic_progenitors|lymph-node_spleen / Manually curated celltypes from each tissue | 4.79e-05 | 174 | 101 | 5 | 029394e107bf7ad58056d2216070aa2e964fff12 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.79e-05 | 174 | 101 | 5 | 72df66319f6efbd88ecf439013d97409fbf3cb52 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.79e-05 | 174 | 101 | 5 | c6087fd0e036ec7f40f0f8f17d1f6ce13ddb5235 | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-GrB-secreting_B_cells|normal_Lymph_Node / Location, Cell class and cell subclass | 4.92e-05 | 175 | 101 | 5 | 29fbdfe1d3bfcb063be2bced0128a33176c5b78f | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.20e-05 | 177 | 101 | 5 | 8a0f0fbb06cdacb99a3fdba0da3e0494b891db4f | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 5.20e-05 | 177 | 101 | 5 | 844017225e9039d1bc621a9630a30c2e9a51b36d | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.20e-05 | 177 | 101 | 5 | 26c25d10aa511b64cc7db43a8deea7b5d31bca96 | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.20e-05 | 177 | 101 | 5 | e9d7682517fb30fd2ad535d59779d718a7024c13 | |
| ToppCell | Healthy-RBC|Healthy / disease group, cell group and cell class | 5.20e-05 | 177 | 101 | 5 | 945d72ab52efa9a9468daace9f9ec676a891d963 | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.34e-05 | 178 | 101 | 5 | fba2e38c05cbf031e0c6d47b1602575fea734a57 | |
| ToppCell | COVID-19-kidney-PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.63e-05 | 180 | 101 | 5 | 493cf8d1a8f2a1ed2672f394a0338b110fd81d88 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.78e-05 | 181 | 101 | 5 | 566249e04dd491e6287ad2101b7b1ab11031ed8b | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 5.78e-05 | 181 | 101 | 5 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.78e-05 | 181 | 101 | 5 | db9528dc7cb0230e4c36cb27da69102c588c7ee9 | |
| ToppCell | 3'_v3-bone_marrow-Hematopoietic_progenitors-Progenitor_Myeloid|bone_marrow / Manually curated celltypes from each tissue | 5.93e-05 | 182 | 101 | 5 | 6745d464c3ff289726aa8164e9a43f407f8e4380 | |
| ToppCell | T_cells-Resident_memory_CD8+_T_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 5.93e-05 | 182 | 101 | 5 | 111d434b89902ec11fb07f41b8ee1a98f3991b61 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D175|Adult / Lineage, Cell type, age group and donor | 5.93e-05 | 182 | 101 | 5 | ad4d74d8b19976e1ccc3c5ba8013199338cf6fd8 | |
| ToppCell | IPF-Lymphoid-ILC_B|Lymphoid / Disease state, Lineage and Cell class | 6.09e-05 | 183 | 101 | 5 | 9b507547e6adf78e46e7f542cd9958224ec5826a | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.41e-05 | 185 | 101 | 5 | 847257d232b9993cad50c814fd4ffeef52385295 | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.74e-05 | 187 | 101 | 5 | 0099def970fbc828756fbf853eca2ce77b8cd342 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.74e-05 | 187 | 101 | 5 | 3912bbb610a4a84791e9bda92a2d57a52c31d29e | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.91e-05 | 188 | 101 | 5 | eea652bab161f19148a883e7e3fe2523b36b3cea | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l32-30|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.91e-05 | 188 | 101 | 5 | c2febf9fd4632af1f922067c3a30e5c50f75f480 | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_hi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.91e-05 | 188 | 101 | 5 | 567b08514d9d84cbb40f9b7a679eec304f023428 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CytoT_GZMK+-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 7.09e-05 | 189 | 101 | 5 | f1129eb122bbc051457c5545f1a267beb988b0f2 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CytoT_GZMK+|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 7.09e-05 | 189 | 101 | 5 | 0b012ee301419fa9ccc387c3ff66c2344b349a97 | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 7.09e-05 | 189 | 101 | 5 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.09e-05 | 189 | 101 | 5 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.27e-05 | 190 | 101 | 5 | e102622f05c7f3e1bd8b224ea159d57033793ee0 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.45e-05 | 191 | 101 | 5 | de2cd94ee88a7754f86d39469e38374d668210c7 | |
| ToppCell | E17.5-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.45e-05 | 191 | 101 | 5 | efe0cb0b6602621f5eda72a723b83b38bf15607f | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.45e-05 | 191 | 101 | 5 | bae388e0e9447d576e68465d73d8313ef6925ffa | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.45e-05 | 191 | 101 | 5 | 0ba5b112a82e489f5a21966f78a403a7436ce73b | |
| ToppCell | E17.5-Endothelial-proliferative_endothelial_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.45e-05 | 191 | 101 | 5 | 00676c598f6dae0ff9158d064248f1265432f3e1 | |
| ToppCell | RA-09._Endothelium_I|World / Chamber and Cluster_Paper | 7.45e-05 | 191 | 101 | 5 | c8a0c2af119bc34a8f694a7d30642f28002c84b9 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic-Non-classical_Monocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.45e-05 | 191 | 101 | 5 | 47a2afc4102199b4bc76bd01b2967c8016186462 | |
| ToppCell | COVID-19-kidney-Myeloid|kidney / Disease (COVID-19 only), tissue and cell type | 7.64e-05 | 192 | 101 | 5 | 441cd1ec171f643b28e1f6f9c04def629cc7391b | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.64e-05 | 192 | 101 | 5 | 27723f4e320e49d4a3daafa2d8d3946ff79fab64 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.64e-05 | 192 | 101 | 5 | 0a54c79dcfdeb99e3b512d42b22359618cfd17e9 | |
| ToppCell | droplet-Skin-nan-21m-Epithelial-stem_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.64e-05 | 192 | 101 | 5 | 96f23d6e8604d1cb24910d3118d8171b57c93e14 | |
| ToppCell | RA-09._Endothelium_I|RA / Chamber and Cluster_Paper | 7.64e-05 | 192 | 101 | 5 | 8a1b1c3e83a68ad74f8f4eb00455c9e41aa57cfc | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMK+-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 7.64e-05 | 192 | 101 | 5 | ed1fb700d3e8f00495727d61e164fc0b70274fd0 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMK+|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 7.64e-05 | 192 | 101 | 5 | 6779b0294bb058e748e22b795b6a381c4add37e9 | |
| ToppCell | COVID-19-kidney-Myeloid|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.64e-05 | 192 | 101 | 5 | 0b9d22a222f1201e375f8e55cace9ef939febae4 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.82e-05 | 193 | 101 | 5 | 173f1d83133f5ffa88e2a75d28835ad7acd2aa90 | |
| ToppCell | Control-Lymphoid-Proliferating_CD4_T_cells|Control / Condition, Lineage and Cell class | 7.82e-05 | 193 | 101 | 5 | 33d409d6ed1c606337248587ad997ac5f67f081d | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 7.82e-05 | 193 | 101 | 5 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.82e-05 | 193 | 101 | 5 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.82e-05 | 193 | 101 | 5 | 5578f7cb3ec68c9a38cc5304b618b81283024d5e | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_T_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.82e-05 | 193 | 101 | 5 | a594f89a18273797506287d9e22f72abe53e4920 | |
| ToppCell | COVID-19-kidney-T-cells-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.82e-05 | 193 | 101 | 5 | 5b84fa640cf30dea55fde53b810f850ff946d253 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.02e-05 | 194 | 101 | 5 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | Megakaryocytic-erythropoietic-Erythro-cells-Polychromatic_Erythroblast|World / Lineage, cell class and subclass | 8.02e-05 | 194 | 101 | 5 | 008bb0072f414a48d052429101bdc990ee4f80c2 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.02e-05 | 194 | 101 | 5 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.02e-05 | 194 | 101 | 5 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Granulocytic|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.02e-05 | 194 | 101 | 5 | 607b5d194ba56efa9b106f10f89368fc103712a0 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.02e-05 | 194 | 101 | 5 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Granulocytic-Neutrophil|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.02e-05 | 194 | 101 | 5 | f5367072b259ae170cf0df3d4d871ab41be29d29 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 8.21e-05 | 195 | 101 | 5 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 8.21e-05 | 195 | 101 | 5 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 8.21e-05 | 195 | 101 | 5 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.21e-05 | 195 | 101 | 5 | 5812b1615676f3b77eb4769216b98b360c417c0d | |
| ToppCell | BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.41e-05 | 196 | 101 | 5 | 6d80e23f6a1725a3f5ea7263233c55c2ea56f977 | |
| ToppCell | BAL-Control-Myeloid-Myeloid|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.41e-05 | 196 | 101 | 5 | bf1d3fae8c01bb3d17c2dafad92b94937c663acd | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.41e-05 | 196 | 101 | 5 | ea8eceacc5d5e1a22b77c31e7c45985dc7bb15de | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Proliferating-Cycling_Progenitors|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 8.41e-05 | 196 | 101 | 5 | 5905f0e3061a6b98b7a33d64c782c3dda2cd51ef | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 8.41e-05 | 196 | 101 | 5 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.41e-05 | 196 | 101 | 5 | 3dd7ed1dfac8d90c8a44f0ae00128bb46d9ef496 | |
| ToppCell | BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.41e-05 | 196 | 101 | 5 | 4f649e3bfd21f21682678828673843a7d51c4ff2 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.41e-05 | 196 | 101 | 5 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | BAL-Control-Myeloid-Myeloid|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.41e-05 | 196 | 101 | 5 | 799c290fb3dfacb666dd0dc3c43ec8a86b697ec7 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.41e-05 | 196 | 101 | 5 | 0f3c7fd450aaa1f866b8558692534c0ea2a34e75 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 9.47e-05 | 49 | 53 | 4 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Computational | Neighborhood of CASP8 | 3.05e-04 | 27 | 53 | 3 | GNF2_CASP8 | |
| Disease | smoking status measurement | GPM6A DLGAP1 LMTK2 SNRK REST THSD7B RPL7L1 CTNNA3 PLXNA4 C12orf42 NAV2 DNAH8 PLXNA2 PMFBP1 | 2.60e-05 | 1160 | 97 | 14 | EFO_0006527 |
| Disease | Schizophrenia | GPM6A DLGAP1 ITGA8 REST PITPNM1 PTPN5 S100A9 IGF2BP2 SRGAP3 OXSR1 ATM PLXNA2 | 3.31e-05 | 883 | 97 | 12 | C0036341 |
| Disease | Drug habituation | 3.99e-05 | 115 | 97 | 5 | C0013170 | |
| Disease | Substance-Related Disorders | 3.99e-05 | 115 | 97 | 5 | C0236969 | |
| Disease | Drug abuse | 3.99e-05 | 115 | 97 | 5 | C0013146 | |
| Disease | Drug Use Disorders | 3.99e-05 | 115 | 97 | 5 | C0013222 | |
| Disease | Drug Dependence | 3.99e-05 | 115 | 97 | 5 | C1510472 | |
| Disease | Substance Dependence | 3.99e-05 | 115 | 97 | 5 | C0038580 | |
| Disease | Substance Use Disorders | 3.99e-05 | 115 | 97 | 5 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 3.99e-05 | 115 | 97 | 5 | C0029231 | |
| Disease | Prescription Drug Abuse | 3.99e-05 | 115 | 97 | 5 | C4316881 | |
| Disease | Substance abuse problem | 4.16e-05 | 116 | 97 | 5 | C0740858 | |
| Disease | serum gamma-glutamyl transferase measurement | FSIP1 ICE2 MCC LMTK2 CIT S100A9 THADA ENAH NAV2 FLACC1 PMFBP1 KLB | 4.62e-05 | 914 | 97 | 12 | EFO_0004532 |
| Disease | Malignant neoplasm of breast | EVL SYNE1 KTN1 KCNIP3 CNNM4 STX5 SRGAP3 MACF1 ATM BCAR3 NIPBL FLACC1 ZNF541 | 5.03e-05 | 1074 | 97 | 13 | C0006142 |
| Disease | hemoglobin A1 measurement | 5.54e-05 | 520 | 97 | 9 | EFO_0007629 | |
| Disease | mean reticulocyte volume | SOX6 DLGAP1 ZFAT REST SPECC1 PTPN2 THADA IGF2BP2 OXSR1 ATM PMFBP1 | 6.42e-05 | 799 | 97 | 11 | EFO_0010701 |
| Disease | X-Linked Emery-Dreifuss Muscular Dystrophy | 2.22e-04 | 7 | 97 | 2 | C0751337 | |
| Disease | myeloid white cell count | 2.58e-04 | 937 | 97 | 11 | EFO_0007988 | |
| Disease | stromal cell-derived factor 1 alpha measurement | 3.86e-04 | 43 | 97 | 3 | EFO_0008293 | |
| Disease | tauopathy (implicated_via_orthology) | 4.73e-04 | 10 | 97 | 2 | DOID:680 (implicated_via_orthology) | |
| Disease | Paranoia | 5.77e-04 | 11 | 97 | 2 | C1456784 | |
| Disease | disease recurrence, colon carcinoma | 6.40e-04 | 51 | 97 | 3 | EFO_0004952, EFO_1001950 | |
| Disease | cataract (biomarker_via_orthology) | 8.15e-04 | 13 | 97 | 2 | DOID:83 (biomarker_via_orthology) | |
| Disease | Hereditary Motor and Sensory-Neuropathy Type II | 8.15e-04 | 13 | 97 | 2 | C0270914 | |
| Disease | Autosomal recessive primary microcephaly | 1.09e-03 | 15 | 97 | 2 | cv:C3711387 | |
| Disease | pre-malignant neoplasm (biomarker_via_orthology) | 1.41e-03 | 17 | 97 | 2 | DOID:0060071 (biomarker_via_orthology) | |
| Disease | reaction time measurement | 1.49e-03 | 658 | 97 | 8 | EFO_0008393 | |
| Disease | alpha synuclein measurement | 1.58e-03 | 18 | 97 | 2 | EFO_0009323 | |
| Disease | unipolar depression, bipolar disorder | 1.78e-03 | 156 | 97 | 4 | EFO_0003761, MONDO_0004985 | |
| Disease | cancer (implicated_via_orthology) | 1.94e-03 | 268 | 97 | 5 | DOID:162 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | 2.22e-03 | 702 | 97 | 8 | C0009402 | |
| Disease | FEV/FEC ratio | USP34 MCC ITGA8 REST THADA IGF2BP2 KIF15 SRGAP3 THG1L NAV2 SSH2 | 2.34e-03 | 1228 | 97 | 11 | EFO_0004713 |
| Disease | Primary microcephaly | 2.37e-03 | 22 | 97 | 2 | C0431350 | |
| Disease | Autosomal Recessive Primary Microcephaly | 2.37e-03 | 22 | 97 | 2 | C3711387 | |
| Disease | leptin measurement | 2.44e-03 | 81 | 97 | 3 | EFO_0005000 | |
| Disease | vital capacity | THOC1 SOX6 USP34 ZFAT KIF1A FSIP1 SYNE1 IGF2BP2 GLI3 CTNNA3 PMFBP1 | 2.46e-03 | 1236 | 97 | 11 | EFO_0004312 |
| Disease | response to TNF antagonist, joint damage measurement | 3.05e-03 | 25 | 97 | 2 | EFO_0004653, EFO_0005413 | |
| Disease | neuroticism measurement | 3.06e-03 | 909 | 97 | 9 | EFO_0007660 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SENKLCMDLMTERLQ | 176 | Q4AC99 | |
| DEEMNEICKTEFQMR | 771 | O75815 | |
| CRCSMEEKVTEMKNS | 61 | A8MVX0 | |
| MCDRSNAKQIVSEML | 396 | O95782 | |
| NMMAKTLEECRVTLE | 531 | Q5M775 | |
| SVNMDQAMVKSESCQ | 296 | O14490 | |
| TMEALKTTCTMLEEQ | 1011 | O14578 | |
| RELSMENQCSLDMKS | 1041 | Q5TC82 | |
| KMQDTMEENSESALR | 336 | P17706 | |
| VMITNIEEMNEKCTE | 396 | P54829 | |
| EKMCRTLEDQMNEHR | 1246 | P12883 | |
| SMDELLKEIQAMSQC | 56 | O95747 | |
| DSIVCEMKMDTDQNT | 941 | Q13127 | |
| DVMVSDCRSKEQMSD | 101 | Q5SRR4 | |
| VCEKMTMTTENPNQT | 6 | Q8NGN2 | |
| MGMCSRQERIQKDID | 1 | Q8N3A8 | |
| DTSQTCRVNGIKMEM | 1411 | P10071 | |
| RTSQEMEMLRKQVEC | 1321 | Q9NS87 | |
| SSEMDLRCAEMKQNF | 156 | Q96Q35 | |
| VIVKMDNSRDLNMDC | 276 | P78386 | |
| MKIVCQSEVRDFSAM | 1116 | Q38SD2 | |
| ASAMQQMLTESCKNR | 386 | Q6UWE0 | |
| ENFLRMCESTELNMT | 196 | P51674 | |
| MMEFVRETCSQELKN | 1181 | O60318 | |
| MQMDNLESRVALECK | 1276 | O75051 | |
| MQMDNLESRVALECK | 1276 | Q9HCM2 | |
| LEVLTRDLMEQCSNM | 1106 | O60486 | |
| RTMFQKIVDACEQMQ | 681 | P51160 | |
| MSEQSICQARASVMV | 1 | Q9UI08 | |
| LSCIRDNEIQMDMTL | 1126 | Q96JB1 | |
| MKDQQTVIMTECTSL | 1 | Q9H0H0 | |
| ESCQKDENIMRSMQL | 231 | Q6PIL6 | |
| ESCQKDENIMRSMQL | 251 | Q9NS61 | |
| TEMCVKMIRRVNDEE | 1886 | Q6KC79 | |
| TKDRCKQLTQEMMTE | 351 | Q86UP2 | |
| DSQTMLLQRMACEVA | 236 | Q8IWU2 | |
| TSEACRMILEIMQKE | 251 | Q9Y6M1 | |
| MKDESARMSQEKQVT | 266 | Q8TDB8 | |
| KMENVTRMVVCDLGN | 716 | P53708 | |
| LEVKQRVNSGCVMME | 5106 | Q9UPN3 | |
| QRMATDMQRKRSSEC | 96 | Q86VX9 | |
| TNKIEISMDCIRMQD | 86 | Q9H3D4 | |
| ISMDCIRMQDSDLSD | 91 | Q9H3D4 | |
| QMKIMISECESSVNQ | 766 | Q66GS9 | |
| DTSNDIIVLAKNMCM | 696 | Q9UI47 | |
| CEKTMEVMRNSQETL | 2931 | Q13315 | |
| LEECKSNAERMSMLV | 421 | P23508 | |
| NSMDLDMKQDCSQLV | 926 | Q9ULT8 | |
| ISEMDMSCEVNECRK | 371 | Q659A1 | |
| TIMHDENKENRMSCT | 1186 | Q14185 | |
| VMTDESKDNRMSCTV | 1191 | Q92608 | |
| IMQDESKENRMSCTV | 1211 | Q9H7D0 | |
| CEKEMNENMRATLAT | 196 | Q9P2H0 | |
| ELREKLCSIQSENMM | 1406 | Q8IWJ2 | |
| MMKENVLESTSCLSE | 391 | Q8NA03 | |
| SQDIQEMKDESARMS | 236 | P11169 | |
| ENTMDIFKCQQSMVS | 311 | Q86Z14 | |
| ESKATSCMSEMQVIN | 181 | Q86TM3 | |
| MSEQSICQARAAVMV | 1 | Q8N8S7 | |
| LVMRLATKEQEMQEC | 76 | Q15007 | |
| MCLQDVESMNSSRFV | 96 | Q6UWW8 | |
| TSEVNCTIMMKAQAA | 226 | A5D8W1 | |
| LEACQKDENIMSSMQ | 236 | Q9Y2W7 | |
| LKMTAVNETQEKMCE | 1631 | Q02224 | |
| VADTEIRTIQMKMCR | 31 | Q68DL7 | |
| NSREMSRDSKCIIQM | 16 | Q12756 | |
| QCQEEELTQMVSTMS | 191 | Q14681 | |
| LEKQQCMATELEMTV | 431 | Q8TBY8 | |
| KRSVPCDSNEANEMM | 11 | Q9NS26 | |
| CESNRSTEIVSMEEM | 646 | Q6YHU6 | |
| MTCKMSQLERNIETI | 1 | P06702 | |
| EITAMQDRCLNMQEK | 5296 | Q8NF91 | |
| MISSCTTRKMAEQEQ | 1 | Q6DKI1 | |
| SLEDMRSNNVEDCKM | 616 | Q9BXS9 | |
| RSNNVEDCKMMQVSS | 621 | Q9BXS9 | |
| CMDSEAETVMQLRNE | 1896 | Q8IVL1 | |
| QRTMTDVADCLKVFM | 656 | Q7Z3Z4 | |
| EMVQENTSKTHSCDM | 596 | Q8WWX8 | |
| DSQVSTFTMECMKEL | 151 | Q8NEM2 | |
| AAAMCMVVTRTEKDS | 396 | P10155 | |
| QEANDSETLTMIMDC | 216 | Q9NRH2 | |
| KDVAIDMMDSRTSQQ | 241 | Q13190 | |
| EMTRTEQEDSSCMEK | 141 | P35712 | |
| KRSVPCDSNEANEMM | 11 | Q9NY87 | |
| MSTVICMKQREEEFL | 1 | Q96LP6 | |
| AMAMCSVVQKSTNVE | 91 | Q5U649 | |
| KTVEDIMTQLQDCFM | 371 | Q6P4Q7 | |
| EETARMLAQRMAKCN | 246 | O00562 | |
| METRAAENTAIFMCK | 1 | Q9P243 | |
| MEISKAASEMLTNNC | 156 | Q86T26 | |
| TSKEIRTELEMQMVC | 271 | Q76I76 | |
| SRSDKHTVMDMCNQV | 311 | O43295 | |
| EEEMVEMKEQCSAQR | 116 | Q9UQP3 | |
| KRSVPCDSNEANEMM | 11 | Q9BXN6 | |
| QLMTKCAQTVMEELE | 81 | Q9NWX6 | |
| DMKEITNCVRQAMRS | 1106 | O94964 | |
| NVKDASMTQALCRMI | 261 | Q8NB14 | |
| MKNIIAEMEQASRQC | 301 | Q9BZW7 | |
| EMINECTEQTLFRMH | 271 | Q9H892 | |
| GTQLQSMEDRMECES | 166 | Q6R2W3 | |
| QEFISKCMESLMIAS | 1136 | Q70CQ2 | |
| DNRSAEMMECLKQTN | 841 | Q9C0I4 | |
| QIECDSEDMKMRAKQ | 601 | Q96FV9 | |
| AVESQRMCELMKQQE | 366 | P40222 | |
| MMISSETQDRVTELC | 1091 | Q9H0D2 | |
| SEMNVIAADMCTNAR | 431 | Q96BF6 |